Long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma
Saved in:
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1890605999 | ||
| 003 | DE-627 | ||
| 005 | 20240604151741.0 | ||
| 007 | tu | ||
| 008 | 240604s2023 gw ||||| m 00| ||eng c | ||
| 035 | |a (DE-627)1890605999 | ||
| 035 | |a (DE-599)KXP1890605999 | ||
| 035 | |a (OCoLC)1437545056 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-DE-BW | ||
| 082 | 0 | 4 | |a 616.994 |q DE-101 |
| 082 | 0 | 4 | |a 610 |q DE-101 |
| 084 | |a 33 |2 sdnb | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Porth, Isabel |d 1993- |e VerfasserIn |0 (DE-588)120988559X |0 (DE-627)1697803202 |4 aut | |
| 245 | 1 | 0 | |a Long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma |c vorgelegt von Isabel Porth ; Referent: Prof. Dr. med. Timo Gaiser |
| 264 | 1 | |a Heidelberg |c 2023 | |
| 300 | |a VIII, 74 Seiten |b Illustrationen, Diagramme | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 502 | |b Dissertation |c Ruprecht-Karls-Universität zu Heidelberg |d 2024 | ||
| 650 | 4 | |a gastric cancer | |
| 650 | 0 | 7 | |0 (DE-588)4661821-1 |0 (DE-627)337553696 |0 (DE-576)214774929 |a Trastuzumab |2 gnd |
| 650 | 4 | |a HER2 | |
| 650 | 4 | |a next-generation sequencing | |
| 650 | 4 | |a PD-L1 | |
| 655 | 7 | |a Hochschulschrift |0 (DE-588)4113937-9 |0 (DE-627)105825778 |0 (DE-576)209480580 |2 gnd-content | |
| 700 | 1 | |a Gaiser, Timo |d 1975- |e AkademischeR BetreuerIn |0 (DE-588)1030402280 |0 (DE-627)735221685 |0 (DE-576)378226533 |4 dgs | |
| 751 | |a Heidelberg |0 (DE-588)4023996-2 |0 (DE-627)106300814 |0 (DE-576)208952578 |4 uvp | ||
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |a Porth, Isabel, 1993 - |t Long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma |d Heidelberg, 2024 |h 1 Online-Ressource (88 Seiten) |w (DE-627)1885687184 |
| 951 | |a BO | ||
| 992 | |a 20240610 | ||
| 993 | |a Thesis | ||
| 998 | |g 120988559X |a Porth, Isabel |m 120988559X:Porth, Isabel |d 60000 |d 60001 |e 60000PP120988559X |e 60001PP120988559X |k 0/60000/ |k 1/60000/60001/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1890605999 |e 4536066314 | ||
| BIB | |a Y | ||
| JSO | |a {"type":{"bibl":"thesis"},"physDesc":[{"extent":"VIII, 74 Seiten","noteIll":"Illustrationen, Diagramme"}],"recId":"1890605999","language":["eng"],"title":[{"title_sort":"Long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma","title":"Long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma"}],"origin":[{"publisherPlace":"Heidelberg","dateIssuedDisp":"2023","dateIssuedKey":"2023"}],"id":{"eki":["1890605999"]},"name":{"displayForm":["vorgelegt von Isabel Porth ; Referent: Prof. Dr. med. Timo Gaiser"]},"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Porth, Isabel","given":"Isabel","family":"Porth"},{"given":"Timo","family":"Gaiser","role":"dgs","roleDisplay":"AkademischeR BetreuerIn","display":"Gaiser, Timo"}],"noteThesis":["Dissertation. - Ruprecht-Karls-Universität zu Heidelberg. - 2024"]} | ||
| SRT | |a PORTHISABELONGTERMRE2023 | ||